TABLE 1.

Demographic and clinical information

	Control (n = 47)	PD (n = 47)	P-value
Female/male, n	24/23	25/22	1.000
Age, y, mean (SD)	62.2 (8.8)	65.8 (10.1)	0.074
Education, y, mean (SD)	15.4 (3.7)	14.4 (3.8)	0.193
MoCA	25.8 (2.6)	24.8 (3.9)	0.139
Disease duration, y, mean (SD)	—	5.5 (4.8)	—
UPDRS I, mean (SD)	—	9.1 (6.5)	—
UPDRS II, mean (SD)	—	8.8 (7.5)	—
UPDRS III, mean (SD)	—	21.8 (15.2)	—
Total UPDRS, mean (SD)	—	39.6 (24.8)	—
LEDD, mean (SD)	—	679 (487)	—

Data represent the mean (SD), except for sex.

Disease duration was calculated as years since diagnosis; MoCA, Montreal Cognitive Assessment; UPDRS I, non-motor experience of daily living; UPDRS II, motor experience of daily living; UPDRS III, motor examination; LEDD, levodopa equivalent daily dosage; Total UPDRS, UPDRS I + UPDRS II + UPDRS III.